Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
RYZODEG 70/30 FLEXTOUCH, RYZODEG 70/30 PENFILL (Novo Nordisk Pharmaceuticals Pty Ltd)
Product name
RYZODEG 70/30 FLEXTOUCH, RYZODEG 70/30 PENFILL
Date registered
Evaluation commenced
Decision date
Approval time
250 working days (255)
Active ingredients
insulin degludec (rys), insulin aspart (rys)
Registration type
EOI
Indication
RYZODEG 70/30 FLEXTOUCH, RYZODEG 70/30 PENFILL (solution for injection) are now also indicated for use in diabetes mellitus in patients aged 6 years and older.